Buchumschlag

New Therapies of Liver Diseases

In this Special Issue of the journal, advancements in the treatment of liver diseases are illustrated by international experts in the field. New treatment options for primary biliary cirrhosis and, hopefully, primary sclerosing cholangitis are discussed. Up-to-date pharmacological therapy for preven...

Ausführliche Beschreibung

Gespeichert in:
Format: Online
Sprache:Englisch
Veröffentlicht: MDPI - Multidisciplinary Digital Publishing Institute 2022
Schlagworte:
tolvaptan
cirrhotic ascites
survival rate
furosemide
primary biliary cholangitis
autoantibodies
ursodeoxycholic acid
treatment response
second line therapy
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
clinical trials
ursodeoxycholic acid (UDCA)
Farnesoid X Receptor (FXR) agonist
Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists
liver cancer
systemic treatment
immunotherapy
real-world
unresectable hepatocellular carcinoma
cirrhosis
decompensation
bleeding
varices
survival
infection
alcoholic hepatitis
acute-on-chronic liver failure
cholangiocarcinoma
colorectal cancer metastases
hepatocellular carcinoma
liver transplantation
Milan criteria
alpha-fetoprotein
solid organ transplantation
liver injury
immunosuppressant
SARS-CoV-2
humoral response
vaccination
portal-systemic shunt
ammonia
vigilance
HBV
HDV
antivirals
functional cure
pharmacology
acute-on-chronic liver failure (ACLF)
liver transplantation (LT)
decompensated cirrhosis
portal hypertension
ascites
non-selective beta-blockers
TIPS
rifaximin
human albumin
statins
targeted therapy
effective hypovolemia
anti-mineralocorticoids
loop diuretics
vaptans
n/a
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
Online-Zugang:ONIX_20220506_9783036538594_122
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge